Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Tiziana Life Sciences Ltd (TLSA)

$0.89 -12.50% NASDAQ: TLSA · 15-min delayed
  • Public · NASDAQ: TLSA
  • 10 employees
$157.8MMarket cap
10Employees
TLSANASDAQ
2018IPO

About Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$157.8M
NASDAQ: TLSA
$0.89 -12.50%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.89 $2.50

52-week range

Market cap
$157.8M
Shares outstanding
177.3M
Open
Day range
Prev close
Volume
IPO date
Nov 20, 2018

Tiziana Life Sciences Ltd (TLSA) Stock Price

  • Trading 64% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Tiziana Life Sciences Ltd.

Write a review
Newsroom

News about Tiziana Life Sciences Ltd

News & sentiment via Polygon.io

FAQ

Tiziana Life Sciences Ltd: frequently asked questions

Is Tiziana Life Sciences Ltd an American company?

Tiziana Life Sciences Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Tiziana Life Sciences Ltd publicly traded?

Yes — Tiziana Life Sciences Ltd is a publicly traded company. Its stock trades under the ticker symbol TLSA on the NASDAQ.

What does Tiziana Life Sciences Ltd do?

Tiziana Life Sciences Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →